| In vivo anti-tumor activity of the organometallic ruthenium (II)-arene complex [Ru (η 6-p-cymene) Cl 2 (pta)](RAPTA-C) in human ovarian and colorectal carcinomas A Weiss, RH Berndsen, M Dubois, C Müller, R Schibli, AW Griffioen, ... Chemical Science 5 (12), 4742-4748, 2014 | 286 | 2014 |
| A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α-and β−-radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted … C Müller, K Zhernosekov, U Köster, K Johnston, H Dorrer, A Hohn, ... Journal of nuclear medicine 53 (12), 1951-1959, 2012 | 280 | 2012 |
| Short‐term dietary restriction and fasting precondition against ischemia reperfusion injury in mice JR Mitchell, M Verweij, K Brand, M Van De Ven, N Goemaere, ... Aging cell 9 (1), 40-53, 2010 | 269 | 2010 |
| Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice C Müller, M Bunka, S Haller, U Köster, V Groehn, P Bernhardt, ... Journal of nuclear medicine 55 (10), 1658-1664, 2014 | 204 | 2014 |
| 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617 CA Umbricht, M Benešová, RM Schmid, A Türler, R Schibli, ... EJNMMI research 7, 1-10, 2017 | 189 | 2017 |
| DOTA conjugate with an albumin-binding entity enables the first folic acid–targeted 177Lu-radionuclide tumor therapy in mice C Müller, H Struthers, C Winiger, K Zhernosekov, R Schibli Journal of Nuclear Medicine 54 (1), 124-131, 2013 | 178 | 2013 |
| High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats M Meli, A Kipar, C Müller, K Jenal, E Gönczi, N Borel, D Gunn-Moore, ... Journal of Feline Medicine and Surgery 6 (2), 69-81, 2004 | 158 | 2004 |
| Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer C Müller, CA Umbricht, N Gracheva, VJ Tschan, G Pellegrini, P Bernhardt, ... European journal of nuclear medicine and molecular imaging 46, 1919-1930, 2019 | 155 | 2019 |
| Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application C Müller, KA Domnanich, CA Umbricht, NP van der Meulen The British journal of radiology 91 (1091), 20180074, 2018 | 155 | 2018 |
| Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor–positive tumors A Bettio, M Honer, C Müller, M Brühlmeier, U Müller, R Schibli, V Groehn, ... Journal of Nuclear Medicine 47 (7), 1153-1160, 2006 | 151 | 2006 |
| “Click-to-Chelate”: In Vitro and In Vivo Comparison of a 99mTc(CO)3-Labeled N(τ)-Histidine Folate Derivative with Its Isostructural, Clicked 1,2,3-Triazole Analogue TL Mindt, C Müller, M Melis, M de Jong, R Schibli Bioconjugate chemistry 19 (8), 1689-1695, 2008 | 149 | 2008 |
| Folic acid conjugates for nuclear imaging of folate receptor–positive cancer C Müller, R Schibli Journal of Nuclear Medicine 52 (1), 1-4, 2011 | 142 | 2011 |
| Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β−-emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate C Müller, M Bunka, J Reber, C Fischer, K Zhernosekov, A Türler, R Schibli Journal of nuclear medicine 54 (12), 2168-2174, 2013 | 126 | 2013 |
| Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate C Müller, J Reber, S Haller, H Dorrer, P Bernhardt, K Zhernosekov, ... European journal of nuclear medicine and molecular imaging 41, 476-485, 2014 | 125 | 2014 |
| Cyclotron production of 44Sc: from bench to bedside NP van der Meulen, M Bunka, KA Domnanich, C Müller, S Haller, ... Nuclear medicine and biology 42 (9), 745-751, 2015 | 118 | 2015 |
| Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics C Müller, C Vermeulen, U Köster, K Johnston, A Türler, R Schibli, ... EJNMMI radiopharmacy and chemistry 1, 1-5, 2017 | 113 | 2017 |
| Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting C Müller, A Hohn, PA Schubiger, R Schibli European journal of nuclear medicine and molecular imaging 33, 1007-1016, 2006 | 97 | 2006 |
| Folate receptor targeted alpha-therapy using terbium-149 C Müller, J Reber, S Haller, H Dorrer, U Köster, K Johnston, ... Pharmaceuticals 7 (3), 353-365, 2014 | 95 | 2014 |
| Synthesis and in Vitro/in Vivo Evaluation of Novel 99mTc(CO)3-Folates C Müller, PA Schubiger, R Schibli Bioconjugate chemistry 17 (3), 797-806, 2006 | 93 | 2006 |
| Prospects in folate receptor-targeted radionuclide therapy C Müller, R Schibli Frontiers in oncology 3, 249, 2013 | 91 | 2013 |
